Cohen Klingenstein’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.5M Hold
15,000
0.19% 61
2026
Q1
$3.2M Hold
15,000
0.1% 91
2025
Q4
$2.57M Hold
15,000
0.08% 104
2025
Q3
$2.01M Hold
15,000
0.06% 119
2025
Q2
$1.46M Hold
15,000
0.05% 142
2025
Q1
$1.09M Hold
15,000
0.04% 153
2024
Q4
$1.08M Hold
15,000
0.04% 155
2024
Q3
$1.22M Hold
15,000
0.04% 159
2024
Q2
$1.6M Hold
15,000
0.06% 140
2024
Q1
$1.46M Hold
15,000
0.05% 151
2023
Q4
$1.17M Hold
15,000
0.05% 156
2023
Q3
$940K Hold
15,000
0.04% 165
2023
Q2
$964K Hold
15,000
0.04% 168
2023
Q1
$795K Hold
15,000
0.04% 174
2022
Q4
$630K Hold
15,000
0.03% 181
2022
Q3
$549K Hold
15,000
0.03% 187
2022
Q2
$639K Hold
15,000
0.03% 184
2022
Q1
$806K Hold
15,000
0.03% 179
2021
Q4
$1.08M Hold
15,000
0.04% 166
2021
Q3
$854K Buy
+15,000
New +$912K 0.04% 189

Other funds holding LRCX

Cohen Klingenstein's LRCX Position: Q2 2026 in Review

Cohen Klingenstein held its Lam Research (LRCX) position steady in Q2 2026 at 15,000 shares worth $6.5M. The position accounts for 0.19% of the portfolio, ranked #61.

Cohen Klingenstein first reported a position in LRCX in Q3 2021 and has held it in 20 quarters since. 1,341 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Cohen Klingenstein held 15,000 shares of Lam Research worth $6.5M as of Q2 2026.
  • Cohen Klingenstein left its Lam Research share count unchanged in Q2 2026.
  • Lam Research made up 0.19% of Cohen Klingenstein's portfolio in Q2 2026, its #61 holding.
  • Cohen Klingenstein first reported a position in Lam Research in Q3 2021 and has held it in 20 quarters since.
  • 1,341 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Cohen Klingenstein's 13F filing for Q2 2026, filed 15 Jul 2026.